These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 19168251)

  • 21. Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors.
    Al-Habori M; Al-Mamari M; Al-Meeri A
    Diabetes Res Clin Pract; 2004 Sep; 65(3):275-81. PubMed ID: 15331208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
    Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
    Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
    Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES).
    Deepa R; Velmurugan K; Arvind K; Sivaram P; Sientay C; Uday S; Mohan V
    Metabolism; 2006 Sep; 55(9):1232-8. PubMed ID: 16919544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3.
    Ziegler D; Rathmann W; Dickhaus T; Meisinger C; Mielck A;
    Diabetes Care; 2008 Mar; 31(3):464-9. PubMed ID: 18039804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediabetes and its relationship with obesity in Mexican adults: The Mexican Diabetes Prevention (MexDiab) Study.
    Guerrero-Romero F; Rodríguez-Morán M; Pérez-Fuentes R; Sánchez-Guillén MC; González-Ortiz M; Martínez-Abundis E; Brito-Zurita O; Madero A; Figueroa B; Revilla-Monsalve C; Flores-Martínez SE; Islas-Andrade S; Rascón-Pacheco RA; Cruz M; Sánchez-Corona J
    Metab Syndr Relat Disord; 2008 Mar; 6(1):15-23. PubMed ID: 18370832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar.
    Bener A; Zirie M; Janahi IM; Al-Hamaq AO; Musallam M; Wareham NJ
    Diabetes Res Clin Pract; 2009 Apr; 84(1):99-106. PubMed ID: 19261345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central obesity but not generalised obesity (body mass index) predicts high prevalence of fatty liver (NRFLD), in recently detected untreated, IGT and type 2 diabetes Indian subjects.
    Sanyal D; Mukhopadhyay P; Pandit K; Mukhopadhyay S; Chowdhury S
    J Indian Med Assoc; 2009 Nov; 107(11):755-8. PubMed ID: 20469778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
    Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
    Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients.
    Radu C; Grigorescu M; Crisan D; Lupsor M; Constantin D; Dina L
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):255-60. PubMed ID: 18836616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The burden of diabetes and impaired fasting glucose in India using the ADA 1997 criteria: prevalence of diabetes in India study (PODIS).
    Sadikot SM; Nigam A; Das S; Bajaj S; Zargar AH; Prasannakumar KM; Sosale A; Munichoodappa C; Seshiah V; Singh SK; Jamal A; Sai K; Sadasivrao Y; Murthy SS; Hazra DK; Jain S; Mukherjee S; Bandyopadhay S; Sinha NK; Mishra R; Dora M; Jena B; Patra P; Goenka K;
    Diabetes Res Clin Pract; 2004 Dec; 66(3):293-300. PubMed ID: 15536027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians.
    Vimaleswaran KS; Radha V; Mohan V
    Metabolism; 2006 Sep; 55(9):1222-6. PubMed ID: 16919542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.
    Uchil D; Pipalia D; Chawla M; Patel R; Maniar S; Narayani ; Juneja A
    J Assoc Physicians India; 2009 Mar; 57():201-4. PubMed ID: 19588647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refined grain consumption and the metabolic syndrome in urban Asian Indians (Chennai Urban Rural Epidemiology Study 57).
    Radhika G; Van Dam RM; Sudha V; Ganesan A; Mohan V
    Metabolism; 2009 May; 58(5):675-81. PubMed ID: 19375591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome does not increase the risk of conversion of impaired glucose tolerance to diabetes in Asian Indians--Result of Indian diabetes prevention programme.
    Ramachandran A; Snehalatha C; Satyavani K; Sivasankari S; Vijay V
    Diabetes Res Clin Pract; 2007 May; 76(2):215-8. PubMed ID: 16982107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.